• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在慢性哮喘模型中,抗原刺激停止后气道炎症和重塑的可逆性。

Reversibility of airway inflammation and remodelling following cessation of antigenic challenge in a model of chronic asthma.

作者信息

Kumar R K, Herbert C, Kasper M

机构信息

Department of Pathology, University of New South Wales, Sydney, Australia.

出版信息

Clin Exp Allergy. 2004 Nov;34(11):1796-802. doi: 10.1111/j.1365-2222.2004.02097.x.

DOI:10.1111/j.1365-2222.2004.02097.x
PMID:15544607
Abstract

BACKGROUND

Asthma is associated with recruitment of eosinophils, accumulation of chronic inflammatory cells in the airway walls, subepithelial fibrosis and other structural changes of airway wall remodelling. The role of ongoing exposure to allergens in their pathogenesis remains unclear.

OBJECTIVE

To examine whether changes of inflammation and remodelling were reversible following cessation of antigenic challenge in a mouse model of chronic asthma.

METHODS

BALB/c mice sensitized to ovalbumin (OVA) were chronically challenged by inhalation of a low mass concentration of antigen for 8 weeks, leading to development of acute-on-chronic airway inflammation, subepithelial fibrosis and other changes of airway wall remodelling. Epithelial injury was assessed by immunohistochemistry, while inflammation and remodelling were quantified by appropriate histomorphometric techniques. Regression of lesions was assessed in animals examined at 1, 2 and 4 weeks after exposure to OVA ceased.

RESULTS

We did not find evidence of airway epithelial injury in this model of low-level chronic inhalational exposure to antigen. Persistence of the recruitment of eosinophils and chronic inflammatory cells in the airway walls was dependent on continuing antigenic challenge, as was persistence of mucous cell hyperplasia/metaplasia. Subepithelial fibrosis and epithelial hypertrophy exhibited delayed reversibility following cessation of exposure to antigen, possibly related to matrix-associated accumulation of transforming growth factor-beta(1).

CONCLUSION

In chronic asthma, low-level antigenic challenge may be required to maintain the inflammatory response in the airway wall, but airway remodelling may persist in its absence.

摘要

背景

哮喘与嗜酸性粒细胞募集、气道壁慢性炎症细胞积聚、上皮下纤维化以及气道壁重塑的其他结构变化有关。持续接触变应原在其发病机制中的作用仍不清楚。

目的

在慢性哮喘小鼠模型中,研究停止抗原激发后炎症和重塑变化是否可逆。

方法

用卵清蛋白(OVA)致敏的BALB/c小鼠通过吸入低质量浓度抗原进行8周的慢性激发,导致慢性气道炎症急性发作、上皮下纤维化及气道壁重塑的其他变化。通过免疫组织化学评估上皮损伤,同时采用适当的组织形态计量学技术对炎症和重塑进行量化。在停止接触OVA后1周、2周和4周检查的动物中评估病变的消退情况。

结果

在这种低水平慢性吸入抗原暴露模型中,我们未发现气道上皮损伤的证据。气道壁中嗜酸性粒细胞和慢性炎症细胞募集的持续存在取决于持续的抗原激发,黏液细胞增生/化生的持续存在也是如此。停止接触抗原后,上皮下纤维化和上皮肥大表现出延迟的可逆性,这可能与转化生长因子-β(1)的基质相关积聚有关。

结论

在慢性哮喘中,可能需要低水平的抗原激发来维持气道壁中的炎症反应,但在无抗原激发的情况下气道重塑可能持续存在。

相似文献

1
Reversibility of airway inflammation and remodelling following cessation of antigenic challenge in a model of chronic asthma.在慢性哮喘模型中,抗原刺激停止后气道炎症和重塑的可逆性。
Clin Exp Allergy. 2004 Nov;34(11):1796-802. doi: 10.1111/j.1365-2222.2004.02097.x.
2
Expression of growth factors by airway epithelial cells in a model of chronic asthma: regulation and relationship to subepithelial fibrosis.慢性哮喘模型中气道上皮细胞生长因子的表达:调控及其与上皮下纤维化的关系
Clin Exp Allergy. 2004 Apr;34(4):567-75. doi: 10.1111/j.1365-2222.2004.1917.x.
3
Comparison of acute inflammatory and chronic structural asthma-like responses between C57BL/6 and BALB/c mice.C57BL/6小鼠和BALB/c小鼠急性炎症与慢性结构哮喘样反应的比较。
Int Arch Allergy Immunol. 2009;149(3):195-207. doi: 10.1159/000199715. Epub 2009 Feb 12.
4
Prior SO2 exposure promotes airway inflammation and subepithelial fibrosis following repeated ovalbumin challenge.先前的二氧化硫暴露会在反复卵清蛋白激发后促进气道炎症和上皮下纤维化。
Clin Exp Allergy. 2008 Oct;38(10):1680-7. doi: 10.1111/j.1365-2222.2008.03053.x. Epub 2008 Jun 23.
5
Involvement of distal airways in a chronic model of experimental asthma.远端气道在实验性哮喘慢性模型中的参与情况。
Clin Exp Allergy. 2005 Oct;35(10):1263-71. doi: 10.1111/j.1365-2222.2005.02306.x.
6
Enhanced airway inflammation and decreased subepithelial fibrosis in interleukin 6-deficient mice following chronic exposure to aerosolized antigen.慢性暴露于雾化抗原后,白细胞介素6缺陷小鼠的气道炎症增强且上皮下纤维化减少。
Clin Exp Allergy. 2004 Aug;34(8):1321-8. doi: 10.1111/j.1365-2222.2004.02013.x.
7
Role of STAT6 and SMAD2 in a model of chronic allergen exposure: a mouse strain comparison study.STAT6和SMAD2在慢性过敏原暴露模型中的作用:一项小鼠品系比较研究。
Clin Exp Allergy. 2009 Jan;39(1):147-58. doi: 10.1111/j.1365-2222.2008.03109.x. Epub 2008 Oct 11.
8
Interleukin-18-deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin-induced asthma model.白细胞介素-18缺陷小鼠在卵清蛋白诱导的哮喘模型中表现出慢性炎症减轻和气道重塑减少。
Clin Exp Immunol. 2008 Dec;154(3):295-304. doi: 10.1111/j.1365-2249.2008.03772.x. Epub 2008 Sep 23.
9
Asthma progression to airway remodeling and bone marrow eosinophil responses in genetically distinct strains of mice.不同基因品系小鼠中哮喘进展为气道重塑及骨髓嗜酸性粒细胞反应
Ann Allergy Asthma Immunol. 2008 Dec;101(6):619-25. doi: 10.1016/S1081-1206(10)60225-6.
10
Quantification of collagen and proteoglycan deposition in a murine model of airway remodelling.气道重塑小鼠模型中胶原蛋白和蛋白聚糖沉积的定量分析。
Respir Res. 2005 Apr 8;6(1):30. doi: 10.1186/1465-9921-6-30.

引用本文的文献

1
Quantification of airway fibrosis in asthma by flow cytometry.通过流式细胞术定量哮喘气道纤维化。
Cytometry A. 2018 Jul;93(9):952-958. doi: 10.1002/cyto.a.23373. Epub 2018 Apr 16.
2
Airway remodeling in asthma: what really matters.哮喘中的气道重塑:真正重要的是什么。
Cell Tissue Res. 2017 Mar;367(3):551-569. doi: 10.1007/s00441-016-2566-8. Epub 2017 Feb 11.
3
Barriers to inhaled gene therapy of obstructive lung diseases: A review.阻塞性肺病吸入式基因治疗的障碍:综述
J Control Release. 2016 Oct 28;240:465-488. doi: 10.1016/j.jconrel.2016.05.031. Epub 2016 May 16.
4
Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33.哮喘的持续存在需要多个涉及2型天然淋巴细胞和IL-33的反馈回路。
J Allergy Clin Immunol. 2015 Jul;136(1):59-68.e14. doi: 10.1016/j.jaci.2014.11.037. Epub 2015 Jan 21.
5
Omalizumab for severe asthma: efficacy beyond the atopic patient?奥马珠单抗治疗严重哮喘:非变应性患者的疗效如何?
Drugs. 2014 Apr;74(5):521-33. doi: 10.1007/s40265-014-0203-y.
6
Compartmental and temporal dynamics of chronic inflammation and airway remodelling in a chronic asthma mouse model.慢性哮喘小鼠模型中慢性炎症和气道重塑的区室化及时间动态变化
PLoS One. 2014 Jan 21;9(1):e85839. doi: 10.1371/journal.pone.0085839. eCollection 2014.
7
Airway hyperresponsiveness is associated with airway remodeling but not inflammation in aging Cav1-/- mice.气道高反应性与气道重塑有关,但与衰老 Cav1-/- 小鼠的炎症无关。
Respir Res. 2013 Oct 21;14(1):110. doi: 10.1186/1465-9921-14-110.
8
A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis.一种新的慢性阻塞性肺疾病短期小鼠模型确定了肥大细胞类胰蛋白酶在发病机制中的作用。
J Allergy Clin Immunol. 2013 Mar;131(3):752-62. doi: 10.1016/j.jaci.2012.11.053. Epub 2013 Feb 4.
9
Are mouse models of asthma appropriate for investigating the pathogenesis of airway hyper-responsiveness?哮喘的小鼠模型是否适合用于研究气道高反应性的发病机制?
Front Physiol. 2012 Jul 31;3:312. doi: 10.3389/fphys.2012.00312. eCollection 2012.
10
An imbalance in C/EBPs and increased mitochondrial activity in asthmatic airway smooth muscle cells: novel targets in asthma therapy?哮喘气道平滑肌细胞中C/EBPs失衡与线粒体活性增加:哮喘治疗的新靶点?
Br J Pharmacol. 2009 Jun;157(3):334-41. doi: 10.1111/j.1476-5381.2009.00188.x. Epub 2009 Apr 3.